The FDA approved of Blenrep in combination with bortezomib and dexamethasone (BVd) for adults with relapsed or refractory multiple myeloma who have received at least two prior therapies.

Secarna Pharmaceuticals has signed an agreement with Scenic Biotech covering the discovery and co-development of oligonucleotides against a novel target.

Kindeva has promoted David Stevens, Chief Operating and Commercial Officer, to the newly created role of President.

Alloy Therapeutics has acquired Spannerwerks LLC, a consultancy that advises biopharmaceutical companies on product development and commercialization.

Aenova is investing in its sterile manufacturing capabilities with the installation of another fill & finish (F&F) line at its Latina, Italy site.

Syngene International, a global CRDMO, is adding a GMP bioconjugation suite at its commercial biologics facility [Unit 3] in Bengaluru. With this new capability, Syngene will offer fully integrated, ...

Schwab-Hautzinger rejoins Roche from her role at BASF as Head of Corporate Communications and Government Relations.

New campus will encompass a 50,000 ft2 manufacturing facility, with an adjacent 50,000 ft2 space for specialized packaging and supply chain operations.

BioMed X has introduced a new research team at its Heidelberg institute for multispecific biologics in the field of immuno-oncology in collaboration with Daiichi Sankyo.